Mechanisms of resistance to TRAIL-induced apoptosis in primary B cell chronic lymphocytic leukaemia

Oncogene

Volumn 21, Issue 44, 2002, Pages 6809-6818

  MacFarlane, Marion ^a   Harper, Nicholas ^a   Snowden, Roger T ^a   Dyer, Martin J S ^a   Barnett, Georgina A ^a   Pringle, J Howard ^a   Cohen, Gerald M ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

c FLIP; Caspases; CD95; DISC; IAPs

Indexed keywords

BISINDOLYLMALEIMIDE; CASPASE 8; CELL SURFACE RECEPTOR; CYCLOHEXIMIDE; FAS ANTIGEN; FAS LIGAND; FLICE INHIBITORY PROTEIN; RNA; TRAIL PROTEIN RECEPTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

ADULT; AGED; APOPTOSIS; ARTICLE; B CELL LEUKEMIA; CELL SURFACE; CELL VIABILITY; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AGED; AGED, 80 AND OVER; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CARRIER PROTEINS; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CASPASE 8; CASPASE 9; CASPASES; CYCLOHEXIMIDE; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; FEMALE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUKEMIA, B-CELL, CHRONIC; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PROTEINS; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; RECEPTORS, TUMOR NECROSIS FACTOR; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

INTRACISTERNAL A-PARTICLES;

EID: 0037015675     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1205853     Document Type: Article

References (56)

1. Ahmad M and Shi Y. (2000). Oncogene, 19, 3363-3371.
2. Almond JB, Snowden RT, Hunter A, Cain K and Cohen GM. (2001). Leukemia, 15, 1388-1397.
3. Ashkenazi A and Dixit VM. (1998). Science, 281, 1305-1308.
4. Ashkenazi A, Pai RC, Fong S, Leung S, Lawrence DA, Marsters SA, Blackie C, Chang L, McMurtrey AE, Herbert A, De Forge L, Koumeris IL, Harris L, Bussiere J, Koeppen H, Shahrokh Z and Schwall RH. (1999). J. Clin. Invest., 104, 155-162.
5. Bodmer J-L, Holler H, Reynard S, Inciguerra P, Schneider P, Jou P, Blenis J and Tschopp J. (2000). Nature Cell Biol., 2, 241-243.
6. Boldin MP, Goncharov TM, Goltsev YV and Wallach D. (1996). Cell, 85, 803-815.
7. Chinnaiyan AM, O'Rourke K, Tewari M and Dixit VM. (1995). Cell, 81, 505-512.
8. Deveraux QL and Reed JC. (1999). Genes Dev., 13, 239-252.
9. Deveraux QL, Leo E, Stennicke HR, Welsh K, Salvesen GS and Reed JC. (1999). EMBO J., 18, 5242-5251.
10. Fulda S, Meyer E and Debatin K-M. (2000). Cancer Res., 60, 3947-3956.
11. Griffith TS, Chin WA, Jackson GC, Lynch DH and Kubin MZ. (1998). J. Immunol., 161, 2833-2840.
12. Griffith TS, Rauch CT, Smolak PJ, Waugh JY, Bojani N, Lynch DH, Smith CA, Goodwin RG and Kubin HZ. (1999). J. Immunol., 162, 2597-2605.
13. Harper N, Farrow SN, Kaptein A, Cohen GM and MacFarlane M. (2001). J. Biol. Chem., 276, 34743-34752.
14. Hennino A, Berard M, Casamayor-Palleja M, Krammer PH and Defrance T. (2000). J. Immunol., 165, 3023-3030.
15. Irmler M, Thome M, Hahne M, Schneider P, Hofmann K, Steiner V, Bodmer JL, Schroter M, Burns K, Mattman C, Rimoldi D, French LE and Tschopp J. (1997). Nature, 388, 190-195.
16. Jiang Y, Woronicz JD, Liu W and Goeddel DV. (1999). Science, 283, 543-546.
17. Jo M, Kim TH, Seol DW, Esplen JE, Dorko K, Billiar TR and Strom SC. (2000). Nat. Med., 6, 564-567.
18. Keane MM, Ettenberg SA, Nau MM, Russell EK and Lipkowitz S. (1999). Cancer Res., 59, 734-741.
19. Keogh SA, Walczak H, Bouchier-Hayes L and Martin SJ. (2000). FEBS Lett., 471, 93-98.
20. Kim K, Fisher MJ, Xu S-Q and El-Deiry WS. (2000). Clin. Cancer Res., 6, 335-346.
21. King D, Pringle JH, Hutchinson M and Cohen GM. (1998). Leukemia, 12, 1553-1560.
22. Kirchoff S, Müller WW, Krueger A, Schmitz I and Krammer PH. (2000). J. Immunol., 165, 6293-6300.
23. Kischkel FC, Hellbardt S, Behrmann I, Germer M, Krammer PH and Peter ME. (1995). EMBO J., 14, 5579-5588.
24. Kischkel FC, Lawrence DA, Chuntharapai A, Schow P, Kim KJ and Ashkenazi A. (2000). Immunity, 12, 611-620.
25. Krueger A, Schmitz I, Baumann S, Krammer PH and Kirchoff S. (2001). J. Biol. Chem., 276, 20633-20640.
26. Lawrence D, Shahrokh Z, Marsters S, Achilles K, Shih D, Mounho B, Hillan K, Totpal K, DeForge L, Schow P, Hooley J, Sherwood S, Pai R, Leung S, Khan L, Gliniak B, Bussiere J, Smith CA, Strom SS, Kelley S, Fox JA, Thomas D and Ashkenazi A. (2001). Nat. Med., 7, 383-385.
27. Lee SH, Shin MS, Park WS, Kim SY, Kim HS, Han JY, Park GS, Dong SH, Pi JH, Kim CS, Lee JY and Yoo NJ. (1999). Oncogene, 18, 3754-3760.
28. Leverkus M, Neumann M, Mengling T, Rauch CT, Brocker EB, Krammer PH and Walczak H. (2000). Cancer Res., 60, 553-559.
29. MacFarlane M, Merrison W, Dinsdale D and Cohen GM. (2000). J. Cell Biol., 148, 1239-1254.
30. Marsters SA, Pitti RM, Donahue CJ, Ruppert S, Bauer KD and Ashkenazi A. (1996). Curr. Biol., 6, 750-752.
31. Mori S, Murakami-Mori K, Nakamura S, Ashkenazi A and Bonavida B. (1999). J. Immunol., 162, 5616-5623.
32. Munshi A, Pappas G, Honda T, McDonnell TJ, Younes A, Li Y and Meyn RE. (2001). Oncogene, 20, 3757-3765.
33. Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz R, Mann M, Krammer PH, Peter HE and Dixit VM. (1996). Cell, 85, 817-827.
34. Nesterov A, Ivashchenko Y and Kraft AS. (2002). Oncogene, 21, 1135-1140.
35. O'Brien KAF, Smith LL and Cohen GM. (1987). Toxic. In Vitro, 1, 85-90.
36. Pai SI, Wu GS, Özören N, Wu L, Jen J, Sidransky D and ElDeiry WS. (1998). Cancer Res., 58, 3513-3518.
37. Plumas J, Jacob M-C, Chaperot L, Molens JP, Sotto JJ and Bensa JC. (1998). Blood, 91, 2875-2885.
38. Rasper DM, Vaillancourt JP, Hadano S, Houtzager VM, Seidon I, Keen SL, Tawa P, Xanthoudakis S, Nasir J, Martindale D, Koop BF, Peterson EP, Thornberry NA, Huang J, Lenardo MT, Hayden MR, Roy S and Nicholson DW. (1998). Cell Death Differ., 5, 271-288.
39. Rozman C and Montserrat E. (1995). New Engl. J. Med., 333, 1052-1057.
40. Scaffidi C, Medema JP, Krammer PH and Peter ME. (1997). J. Biol. Chem., 272, 26953-26958.
41. Scaffidi C, Schmitz I, Krammer PH and Peter ME. (1999). J. Biol. Chem., 274, 1541-1548.
42. Snell V, Clodi K, Zhao S, Goodwin R, Thomas EK, Morris SW, Kadin ME, Cabanillas F, Andreeff M and Younhes A. (1997). Br. J. Haematol., 99, 618-624.
43. Sprick MR, Weigand MA, Rieser E, Rauch CT, Juo P, Blenis J, Krammer PH and Walczak H. (2000). Immunity, 12, 599-609.
44. Sun XM, MacFarlane M, Zhuang J, Wolf BB, Green DR and Cohen GM. (1999). J. Biol. Chem., 274, 5053-5060.
45. Tepper CG and Seldin MF. (1999). Blood, 94, 1727-1737.
46. Walczak H, Miller RE, Ariail K, Gliniak B, Griffith TS, Kubin M, Chin W, Jones J, Woodward A, Le T, Smith C, Smolak P, Goodwin RG, Rauch CT, Schuh JC and Lynch DH. (1999). Nat. Med., 5, 157-163.
47. Walczak H, Bouchon A, Stahl H and Krammer PH. (2000). Cancer Res., 60, 3051-3057.
48. Wang C-Y, Mayo MW, Korneluk RG, Goeddel DV and Baldwin ASJ. (1998). Science, 281, 1680-1683.
49. Wang D, Freeman GJ, Levine H, Ritz J and Robertson MJ. (1997). Br. J. Haematol., 97, 409-417.
50. Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK, Sutherland GR, Smith TD, Rauch C and Smith CA. (1995). Immunity, 3, 673-682.
51. Willems F, Amraoui Z, Vanderheyde N, Verhasselt V, Aksoy E, Scaffidi C, Peter ME, Krammer PH and Goldman M. (2000). Blood, 95, 3478-3482.
52. Xerri L, Devilard E, Hassoun J, Haddad P and Birg F. (1997). Leukemia, 11, 1868-1177.
53. Xerri L, Bouabdallah R, Devilard E, Hassoun J, Stoppa AM and Birg F. (1998). Br. J. Cancer, 78, 225-232.
54. Yeh WC, Pompa JL, McCurrach ME, Shu HB, ELia AJ, Shahinian A, Ng M, Wakeham A, Khoo W, Mitchell K, El-Diery WS, Lowe SW, Goeddel DV and Mak TW. (1998). Science, 279, 1954-1958.
55. Zhang J and Winoto A. (1996). Mol. Cell. Biol., 16, 2756-2763.
56. Zhou T, Song L, Yang P, Wang Z, Lui D and Jope RS. (1999). Nat. Med., 5, 42-48.